Brady Sillman

997 total citations
12 papers, 341 citations indexed

About

Brady Sillman is a scholar working on Virology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Brady Sillman has authored 12 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 8 papers in Infectious Diseases and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Brady Sillman's work include HIV Research and Treatment (12 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (6 papers). Brady Sillman is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (6 papers). Brady Sillman collaborates with scholars based in United States and United Kingdom. Brady Sillman's co-authors include Howard E. Gendelman, Benson Edagwa, JoEllyn McMillan, Nagsen Gautam, Yazen Alnouti, Aditya N. Bade, JoEllyn McMillan, Prasanta K. Dash, Santhi Gorantla and Larisa Y. Poluektova and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Advanced Drug Delivery Reviews.

In The Last Decade

Brady Sillman

12 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brady Sillman United States 9 192 180 71 57 42 12 341
Nathan Smith United States 12 218 1.1× 236 1.3× 102 1.4× 42 0.7× 43 1.0× 16 508
Hang Su United States 9 209 1.1× 149 0.8× 78 1.1× 42 0.7× 22 0.5× 18 354
James R. Hilaire United States 6 96 0.5× 100 0.6× 32 0.5× 25 0.4× 25 0.6× 8 193
Lipa Shah United States 8 123 0.6× 103 0.6× 108 1.5× 45 0.8× 127 3.0× 9 345
Shilpee Sharma United States 9 70 0.4× 123 0.7× 71 1.0× 11 0.2× 45 1.1× 17 292
Sipho Mdanda South Africa 10 39 0.2× 55 0.3× 63 0.9× 14 0.2× 101 2.4× 31 313
Massimo Tempestilli Italy 14 90 0.5× 188 1.0× 92 1.3× 34 0.6× 12 0.3× 35 546
Flora Yang United States 7 118 0.6× 180 1.0× 57 0.8× 14 0.2× 18 0.4× 9 324
Zonglin Qiu China 14 342 1.8× 314 1.7× 132 1.9× 15 0.3× 4 0.1× 27 506
Jesse O’Shea United States 7 118 0.6× 109 0.6× 103 1.5× 6 0.1× 31 0.7× 20 308

Countries citing papers authored by Brady Sillman

Since Specialization
Citations

This map shows the geographic impact of Brady Sillman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brady Sillman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brady Sillman more than expected).

Fields of papers citing papers by Brady Sillman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brady Sillman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brady Sillman. The network helps show where Brady Sillman may publish in the future.

Co-authorship network of co-authors of Brady Sillman

This figure shows the co-authorship network connecting the top 25 collaborators of Brady Sillman. A scholar is included among the top collaborators of Brady Sillman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brady Sillman. Brady Sillman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Islam, Farhana, Srijanee Das, Md Ashaduzzaman, et al.. (2024). Development of an extended action fostemsavir lipid nanoparticle. Communications Biology. 7(1). 917–917. 3 indexed citations
2.
Panja, Sudipta, et al.. (2024). Polymer Delivery Systems for Long-Acting Antiretroviral Drugs. Pharmaceutics. 16(2). 183–183. 8 indexed citations
3.
Sillman, Brady, Vikas Kumar, Balasrinivasa R. Sajja, et al.. (2023). Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model. Frontiers in Pharmacology. 14. 1294579–1294579. 5 indexed citations
4.
Sillman, Brady, Mahmudul Hasan, Srijanee Das, et al.. (2023). Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection. Advanced Drug Delivery Reviews. 200. 115009–115009. 24 indexed citations
5.
Gautam, Nagsen, JoEllyn McMillan, Devendra Kumar, et al.. (2021). Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir. Nature Communications. 12(1). 3453–3453. 32 indexed citations
6.
Su, Hang, Brady Sillman, Edward Makarov, et al.. (2021). Recovery of Latent HIV-1 from Brain Tissue by Adoptive Cell Transfer in Virally Suppressed Humanized Mice. Journal of Neuroimmune Pharmacology. 16(4). 796–805. 9 indexed citations
7.
Hilaire, James R., Aditya N. Bade, Brady Sillman, et al.. (2019). Creation of a long-acting rilpivirine prodrug nanoformulation. Journal of Controlled Release. 311-312. 201–211. 21 indexed citations
8.
Sillman, Brady, et al.. (2018). Neuropathogenesis of human immunodeficiency virus infection. Handbook of clinical neurology. 152. 21–40. 34 indexed citations
9.
Sillman, Brady, Aditya N. Bade, Prasanta K. Dash, et al.. (2018). Creation of a long-acting nanoformulated dolutegravir. Nature Communications. 9(1). 443–443. 96 indexed citations
10.
Edagwa, Benson, JoEllyn McMillan, Brady Sillman, & Howard E. Gendelman. (2017). Long-acting slow effective release antiretroviral therapy. Expert Opinion on Drug Delivery. 14(11). 1281–1291. 46 indexed citations
11.
Gnanadhas, Divya Prakash, Prasanta K. Dash, Brady Sillman, et al.. (2017). Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs. Journal of Clinical Investigation. 127(3). 857–873. 38 indexed citations
12.
McMillan, JoEllyn, Adam M. Szlachetka, Brady Sillman, et al.. (2017). Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques. Antimicrobial Agents and Chemotherapy. 62(1). 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathan Smith Breakdown of academic impact, for papers by Hang Su Breakdown of academic impact, for papers by James R. Hilaire Breakdown of academic impact, for papers by Lipa Shah Breakdown of academic impact, for papers by Shilpee Sharma Breakdown of academic impact, for papers by Sipho Mdanda Breakdown of academic impact, for papers by Massimo Tempestilli Breakdown of academic impact, for papers by Flora Yang Breakdown of academic impact, for papers by Zonglin Qiu Breakdown of academic impact, for papers by Jesse O’Shea
Rankless by CCL
2026